Skip To Main Content
Duk Ki Kim on Muck Rack

Duk Ki Kim

As seen in: Wiley Online Library, PLOS ONE
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Duk Ki

Contact Duk Ki, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Burnout among intensivists and critical care fellows in South Korea: Current status and associated factors

|
By Song I. Lee, Won-Young Kim, Chung-Ang College, Duk Ki Kim
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Lee SI, Kim W-Y, Kim Dk, Suh GY, Kim J, Kim HY, et al. (2025) Burnout among intensivists and critical care fellows in South Korea: Current status and associated factors. PLoS ONE 20(2): e0318495. https://doi.org/10.1371/journal.pone.0318495 Editor: Chinh Quoc Luong, Bach Mai Hospital, VIET NAM Received: September 29, 2024; Accepted: January 16, 2025; Published: February 4, 2025 Copyright: © 2025 Lee et al.
Open in Who Shared Issue with article?

Comparative analysis of immunotherapy responses in small cell lung cancer patients with dermatomyositis

|
By So-Yun Kim, Chaeuk Chung, Duk Ki Kim, Song-Yi Choi
| Wiley Online Library Verified
INTRODUCTION Dermatomyositis (DM), a rare autoimmune inflammatory myopathy, is characterized by muscle weakness and distinctive cutaneous manifestations, including heliotrope rash, Gottron's sign, and facial erythema.1, 2 It is frequently associated with malignancy and small cell lung cancer (SCLC) is the most common cancer often associated with DM.3 Patients with cancer-associated dermatomyositis (CAD) exhibit antitranscription intermediary factor 1-γ (anti-TIF1-γ) antibodies.4 Mutations or...
Open in Who Shared Issue with article?
See all 2 articles